Results 131 to 140 of about 26,689 (268)

Therapeutic apheresis in autoimmune diseases

, 2013
Rolf Bambauer,1 Reinhard Latza,2 Carolin Bambauer,3 Daniel Burgard,4 Ralf Schiel5 1Institute for Blood Purification, Homburg, 2Laboratorium of Medicine, St Ingbert, 3Main Hospital Darmstadt, Darmstadt, 4Herz Zentrum, Cardiology, Völklingen ...
Bambauer R, Latza R, Schiel R, Burgard D, Bambauer C   +4 more
core  

From contamination to fever: The role of endotoxin levels in bacterially contaminated platelet concentrates

Vox Sanguinis, EarlyView.
Abstract Background and Objectives Growth of gram‐negative bacteria in a platelet concentrate (PC) is inevitably accompanied by the accumulation of endotoxin, which is the major component of the outer cell membrane of these organisms. However, less is known about the kinetics of endotoxin accumulation in PC and its biological activity.
Marcel Prax, Lea Debes, Paul Adomeit, Michel‐Andrés García‐Otálora, Carl P. McDonald, Marc Cloutier, Ute Gravemann, Opeyemi Adesina, Morenike Adeoye‐Isijola, Josephine Hubloher, Hellen Sarela, Tanja Vollmer, Oleg Krut, Sandra Ramirez‐Arcos, ISBT Transfusion‐Transmitted Infectious Diseases Working Party “Subgroup on Bacteria”   +14 more
wiley   +1 more source

Kidney transplant outcomes in HLA desensitized patients with pretransplant CDC and/or FCM positive crossmatches

Frontiers in Immunology
BackgroundKidney transplant (KT) candidates with very high calculated panel reactive alloantibody (cPRA >95%) have limited chances to receive an HLA-matched transplant unless they undergo pretransplant desensitization.ObjectiveTo assess the efficacy ...
Johan Noble, Johan Noble, Céline Dard, Diane Giovannini, Hamza Naciri Bennani, Pierre Fournier, Béatrice Bardy, Anne Bourdin, Farida Imerzoukene, Lionel Motte, Florian Terrec, Paolo Malvezzi, Thomas Jouve, Thomas Jouve, Lionel Rostaing, Lionel Rostaing   +15 more
doaj   +1 more source

The Place of Therapeutic Apheresis in Severe Immune‐Related Adverse Events: A Scoping Review of Literature

Journal of Clinical Apheresis, Volume 41, Issue 6, December 2026.
ABSTRACT Immune checkpoint inhibitors (ICIs) have revolutionized the management of patients with cancer. However, they can induce breakdowns in immunologic tolerance, leading to autoimmune diseases, or immune related adverse events (irAEs). These irAEs can sometimes be life threatening, requiring aggressive management, such as immunosuppressant (IS) or
C. Vuillet, O. Moranne, D. Daubin, X. Quantin, P. Palassin, T. Kanouni, A. T. J. Maria, the MonRIO network (Montpellier Réseau Immuno‐Oncologie), Q. Thomas, P. Witkowski Durand Viel, C. Coustal, S. Faure, L. Meunier, L. Hountondji, R. Altwegg, C. Lesage, A. Lamoureux, G. Mouterde, S. Fabre, G. Taieb, F. Esselin, X. Ayriginac, C. Travert, B. Roch, F. Roubille, I. Raingeard, M. Le Quintrec, K. Dessaix, F. Garo, O. Moranne, J‐L. Faillie, P. Palassin, K. Klouche, B. Jauzelon, S. Bisiou, P. Rozier, A. TJ Maria   +36 more
wiley   +1 more source

Registro de aféresis terapéutica de la Sociedad Española de Nefrología. Análisis de la actividad en los últimos 5 años

Nefrología
Resumen: Introducción: La aféresis terapéutica (AFT) es una técnica extracorpórea indicada en múltiples patologías renales y no renales, con recomendaciones establecidas en las Guidelines on the Use of Therapeutic Apheresis in Clinical Practice (ASFA ...
E. Rodríguez, L. Sánchez-Cámara, E. Márquez, A. Herreros, S. Benito, M. Fernández-Lucas, M.V. Rubio, R. Franquelo, R. Escaño, N. Ramos, E. Tamarit, J.M. Benlliure, O. Siverio, M.I. Gallardo, M.P. Valenzuela, E. Davin, N. Martín-Alemany, L.M. Cueto, M.T. Padrón, M.T. Rodrigo de Tomás, A. Aymat, V.R. Mercado, R. García, S.M. Cruz, I. González, L. Medina, E. Sánchez, D. Barraca   +27 more
doaj   +1 more source

Calcineurin Inhibitor–Free, mTOR‐Based Immunosuppression in Chimeric Antigen Receptor T‐Cell Therapy for Post‐Transplant Lymphoproliferative Disorder

eJHaem, Volume 7, Issue 6, December 2026.
ABSTRACT Introduction Relapsed/refractory post‐transplant lymphoproliferative disorder (PTLD) remains a challenging complication after solid organ transplantation (SOT), requiring complex balancing of immune‐suppressive therapy (IST) and lymphoma‐directed therapies. Methods We report the case of a 40‐year‐old female kidney‐pancreas transplant recipient
Maria Mappoura, Yara Hajj Younes, Sisi Wang, Kadiatou Baldet, Carmen De Ramon Ortiz, Sarah Morin, Stavroula Marouridi‐Levrat, Amandine Pradier, Astrid Melotti, Pragallabh Purwar, Chiara Bernardi, Liza Ho, Kristof Egervari, Julie Ducreux, Thomas Longval, Francesco Bertoni, Yves Chalandon, Fadi Haidar, Sophie de Seigneux, Jean Villard, Valérie Olivier, Federico Simonetta   +21 more
wiley   +1 more source

Mediastinal Gray Zone Lymphomas: Diagnostic Challenges, Clinicopathologic Overlap, and Emerging Management Strategies

Hematology Reports
Background: Mediastinal gray zone lymphoma (MGZL) is a rare B-cell lymphoma characterized by overlapping clinicopathologic and molecular features of primary mediastinal B-cell lymphoma (PMBL) and classical Hodgkin lymphoma (CHL).
Tugba Zorlu, Mert Seyhan, Nigar Abdullayeva, Turgay Ulas, Mehmet Sinan Dal   +4 more
doaj   +1 more source

When blood is needed but not available: A proposal for measuring patient‐level blood unavailability

Transfusion, EarlyView.
Shreenik Kundu, Ayla Gerk, Meghan Delaney, Dan Poenaru   +3 more
wiley   +1 more source

Clinical Impact of CTLA4 and LAG3 Single‐Nucleotide Polymorphisms in Multiple Myeloma Patients Treated With BCMA CAR T‐Cell Therapy

Hematological Oncology, Volume 44, Issue 6, November 2026.
ABSTRACT Chimeric antigen receptor (CAR) T‐cell therapy targeting B‐cell maturation antigen (BCMA) is a highly effective treatment option for patients with relapsed refractory multiple myeloma (RRMM). However, reliable biomarkers predicting long‐term treatment response remain elusive. Germline single‐nucleotide polymorphisms (SNPs) in immune checkpoint
Elisa Suter, Martina Bertschinger, Inna Shaforostova, Marie‐Noelle Kronig, Henning Nilius, Ulrike Bacher, Katja Seipel, Thomas Pabst   +7 more
wiley   +1 more source

Update of data from the world apheresis association (WAA) registry

The WAA registry has been active since 2002. It allows bed side registration of safety and efficacy data. The data each center enters is accessible for its own use but also used for merged analysis. Most types of procedures are represented. Treatments of
Griskevicius, Antanas,, Vasilache, Ana-Maria, Glatt, Tanya Nadia, Smargianaki, Sofia, Bojanic, Ines,, Bojanic, Ines, Aandahl, Astrid,, Derfler, Kurt, Griskevicius, Antanas, Bihariesingh, Rosita,, Newman, Elizabeth, Derfler, Kurt,, Newmans, Elizabeth, Ott, Michael, Vrielink, Hans,, Smargianaki, Sofia,, Gasova, Zdenka, Audzijoniene, Judita,, Audzijoniene, Judita, Bihariesingh, Rosita, Blahutova, Sarka, Vasilache, Ana Maria,, Stegmayr, Bernd,, Kielstein, Jan T.,, Kiraka, Grace, Newman, Elizabeth,, Hrdlickova, Radomira,, Deeren, Dries,, Vasilache, Ana Maria, Deeren, Dries, Glatt, Tanya Nadia,, Witt, Volker, Gasova, Zdenka,, Tehuteru, Edi Setiawan,, Tehuteru, Edi Setiawan, Aandahl, Astrid, Berlin, Gösta, Berlin, Gösta,, Vrielink, Hans, Ott, Michael,, Hrdlickova, Radomira, Kiraka, Grace,, Kielstein, Jan T., Witt, Volker,, Stegmayr, Bernd, Blahutova, Sarka,, Hrdlickovar, Radomira   +46 more
core   +1 more source